The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 07, 2025

Filed:

May. 23, 2019
Applicant:

Stellenbosch University, Stellenbosch, ZA;

Inventors:

Novel Njweipi Chegou, Bellville, ZA;

Regan Shane Solomons, Kuils River, ZA;

Gerhard Walzl, Cape Town, ZA;

Masilo Charles Manyelo, Parow Valley, ZA;

Assignee:

STELLENBOSCH UNIVERSITY, Stellenbosch, ZA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/70 (2006.01); G01N 33/68 (2006.01); A61B 5/15 (2006.01); A61B 10/00 (2006.01); G01N 21/64 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6863 (2013.01); A61B 5/15 (2013.01); A61B 2010/0077 (2013.01); A61B 2503/06 (2013.01); G01N 2021/6439 (2013.01); G01N 2333/35 (2013.01);
Abstract

Methods, devices, kits and computer-implemented methods for diagnosing (and optionally treating) tuberculous meningitis (TBM) are provided. In one embodiment, the method comprises testing a cerebrospinal fluid (CSF) sample from a subject suspected of having TBM for the presence of MPO and at least two other biomarkers, at least one of the other biomarkers being selected from the group consisting of IFN-γ, sICAM-1, VEGF-A and CXCL8. For example, the method can comprise testing the sample for MPO, IFN-γ and VEGF-A or for MPO, IFN-γ, sICAM-1 and CXCL8. In another embodiment, the method comprises testing a blood sample from a subject suspected of having TBM for the presence of at least one biomarker selected from the group consisting of adipsin (complement factor D), Ab42 and IL-10, and at least two other biomarkers. In one example, the method comprises testing the sample for the presence of adipsin (complement factor D), Ab42 and EL-10.


Find Patent Forward Citations

Loading…